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This study evaluates the effects of a copper amine oxidase (histaminase) purified from the pea seedling as a free or immobilized enzyme
on asthmalike reactions to inhaled antigen in actively sensitized guinea pig in vivo. Male albino guinea pigs, sensitized with ovalbumin, were
challenged with the antigen given by aerosol; free histaminase or CNBr-Sepharose immobilized histaminase was given intraperitoneally (20
Ag, 3 or 24 h before antigen challenge) or by aerosol (4 Ag, 30 min before or during ovalbumin aerosol). The following parameters were
examined: latency time for the onset of respiratory abnormalities, cough severity score, and occurrence and duration of dyspnea. We also
evaluated lung histopathology, mast cell degranulation, and lung myeloperoxidase and malonydialdehyde levels.
Histaminase significantly reduced the severity of cough and the occurrence of dyspnea and delayed the onset of respiratory abnormalities.
Both enzymes prevented bronchial constriction, pulmonary air space inflation, leukocyte infiltration (evaluated as myeloperoxidase activity),
and lipoperoxidation of cell membranes (evaluated as malonyldialdehyde production). No relevant differences in pharmacological potency
were noted between free or immobilized enzyme.
This study provides evidence that histaminase counteracts acute allergic asthmalike reaction in actively sensitized guinea pigs, raising the
possibility of new therapeutic strategies for allergic asthma in humans.
D 2004 Elsevier B.V. All rights reserved.
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Asthma is a major medical problem but despite decades
of research the therapy of this pathological condition has
remained essentially unchanged for the past 30 years. In
recent years, only few new drugs were proposed for the
treatment of asthma, among them leukotriene receptor
antagonists (Drazen, 1999), antiimmunoglobulin E anti-0014-2999/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.ejphar.2004.09.004
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E-mail address: emanuela.masini@unifi.it (E. Masini).bodies, and phosphodiesterase inhibitors (Spina and Page,
2002a; Sullivan and Meltzer, 2003). Asthma morbidity has
increased worldwide especially among children (Myers,
2000; Hartert and Peebles, 2000). At the moment, there is
a continuous interest in novel therapeutic molecules,
showing powerful antioxidant properties for the treatment
of asthma.
Direct evidence for the role of free radicals in asthma
comes from human studies showing higher antioxidants
levels in the respiratory tract of asthmatics than in normal
subjects (Comhair et al., 1999), and that the level of
bronchial obstruction in asthma is associated with anlogy 502 (2004) 253–264
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matory cells in airway lumen (Calhoun et al., 1992). Mast
cells have long been considered to be of paramount
importance in the pathophysiology of asthma (Rossi and
Olivieri, 1997). In fact, the release of immunoglobulin E
(IgE)-dependent mediators, such as histamine from mast
cells, plays a central role in the pathogenesis of diseases
such as allergic asthma (Galli, 1993; Bradding and
Holgate, 1996; Page et al., 2001). In fact, it has been
shown that the number of mast cells in the smooth muscle
of patients with asthma is inversely correlated with the
degree of airway hyperresponsiveness (Brightling et al.,
2002).
Amine oxidases are ubiquitous enzymes widely dis-
tributed among living organisms (Mondovı`, 1985), which
catalyze the oxidation of monoamines and polyamines.
Histamine and other primary amines released during
anaphylactic reaction undergo oxidative deamination by
amine oxidase with release of corresponding aldehyde,
ammonia, and hydrogen peroxide (Mondovi et al., 1988).
Amine oxidases can be divided into two classes, depend-
ing on whether the prosthetic group is flavin adenine
dinucleotide or 2,4,5 trihydroxyphenylalanine quinone
(TPQ), a cofactor derived from the posttranslational
oxidation of a tyrosine residue (Klinman and Mu, 1994).
This second group of enzymes (CuAO; E.C.1.4.3.6)
contains copper and TPQ; in the Cu-TPQ class, plant
enzymes are, in general, more efficient than animal ones,
probably because they also function through a radical
mechanism which does not operate in the enzymes from
animal sources that have been studied (Bellelli et al.,
2000).
CuAO include the subclass of diamine oxidase which
preferentially oxidize putrescine, cadaverine, and hista-
mine; indeed, diamine oxidase and histaminase are
identical enzymes (Mondovı`, 1985). Recently, we have
found that a copper amine oxidase (histaminase) purified
from the pea seedling has a protective effect on cardiac
anaphylactic response in the guinea pig (Masini et al.,
2002b). Furthermore, it has been demonstrated that
bovine serum CuAO protects the heart from damage
induced by free radical (Mateescu et al., 1997), probably
due to an antioxidant effect of this enzyme against
oxygen free radicals (Mateescu et al., 1997). Because
histamine is a good substrate for the pea seedling enzyme
and a crucial mediator in the early phase of allergic
bronchospasm (Spina and Page, 2002b), we decided to
evaluate the effect of copper diamine oxidase (histami-
nase) purified from pea seedling as a free or immobilized
enzyme on an experimentally induced asthmalike reaction
in guinea pig. Repeated exposure of the guinea pig to
antigen has been demonstrated to cause airway hyper-
responsiveness and leukocyte infiltration of lung tissue,
mimicking histological and pharmacological character-
istics of asthma in humans (Wanner et al., 1990;
Pretolani and Vargaftig, 1993).2. Materials and methods
2.1. Purification, immobilization, and activity of the enzyme
Pea seedling histaminase was purified, according to
McGuirl et al. (1994), with a specific activity of at least 40
IU (micromoles of substrate oxidized per minute) per
milligram protein (one unit being defined as the amount
of enzyme catalyzing the oxidation of 1 Amol of substrate/
min). The enzyme was used as free enzyme or immobilized
on CNBr-Sepharose 6MB (Pharmacia, Uppsala, Sweden)
according to Federico et al. (2000).
The enzymatic activity was assayed with histamine
(104 M) as substrate, using the fluorimetric method of
Matsumoto et al. (1982), in which homovanillic acid is
converted into a highly fluorescent compound by the
released hydrogen peroxide (H2O2) in the presence of
peroxidase. Briefly, the incubation mixture was of the
following composition: 0.1 ml of 0.25 M potassium
phosphate buffer (pH 7.5); 0.1 ml of peroxidase (25,000
IU) solution (0.5 mg/ml); 0.1 ml of homovanillic acid
solution (1 mg/ml); 0.1 ml of sample (plasma 20 mg/ml,
heart 24 mg/ml, lung 23 mg/ml, kidney 21 mg/ml, and
liver 24 mg/ml); 0.1 ml of histamine 104 M.
The standard curve was prepared with serial concen-
trations of H2O2 from 0 to 20 mM, and the fluorescence was
read at kem 426 nm with kex 324 nm in a Perkin Elmer
LS50B spectrofluorimeter. The protein content was meas-
ured by a biuret method (Goa, 1953) using a Perkin Elmer
E9 spectrophotometer.
Inactivated histaminase was obtained by the treatment
with 10–4 M semicarbazide, inhibitor of all the copper-
TPQ-dependent amino oxidases. The excess of the inhibitor
was dialyzed off, and the activity of the enzyme was
checked as above.
2.2. Animals
Seventy-six male adult albino guinea pigs, Dunkin–
Hartley strain, were used. They were purchased from a
commercial dealer (Rodentia, Bergamo, Italy) and quar-
antined for 7 days at 22–24 8C on a 12-h light, 12-h dark
cycle before use. Standard laboratory chow (Rodentia),
fresh vegetables, and water were available ad libitum.
The experimental protocol was designed to comply with
the recommendations of the European Economic Commun-
ity (86/609/CEE) for the care and use of laboratory animals
and was approved by the Animal Care Committee of the
University of Florence (Florence, Italy), in agreement with
the Good Laboratory Practice Rules. At the end of the
treatments, the animals weighed about 350–400 g.
2.3. Treatments
Group 1: a group of six guinea pigs was injected with
saline [5 ml/kg b.w., intraperitoneally (i.p.), plus 5 ml/kg
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were treated with an aerosol of ovalbumin suspended in
saline (5 mg/ml) and used as controls. They are referred to
as naRve animals (group 1).
The remaining 70 guinea pigs were sensitized with 100
mg/kg b.w., i.p., plus 100 mg/kg b.w., s.c., ovalbumin,
suspended in saline (20 mg/ml). Two to three weeks later,
they were challenged with an aerosol of ovalbumin (5 mg/
ml in saline) to verify that sensitization had occurred. The
animals were withdrawn from antigen exposure at the first
sign of respiratory abnormality.
Sixty-eight of 70 guinea pigs developed airway hyper-
responsiveness to the inhaled antigen (sensitized animals).
They were selected for further treatments, as indicated
below.
Group 2: 3 days after ovalbumin challenge, eight guinea
pigs were treated with an injection of 0.5 ml of phosphate
buffer solution, s.c., 24 h before a second challenge with
ovalbumin aerosol, as above reported.
Groups 3 and 4: 12 guinea pigs were treated as described
for group 2, but received an i.p. injection of free histaminase
(group 3) or CNBr-Sepharose immobilized histaminase
(group 4) at a dose of 20 Ag in 500 Al of PBS 3 h before
a second challenge with ovalbumin aerosol, as above
reported.
Groups 5 and 6: 12 guinea pigs were treated as described
for group 2, but received an i.p. injection of free histaminase
(group 5) or CNBr-Sepharose immobilized histaminase
(group 6) at the dose of 20 Ag in 500 Al of buffer, 24 h
before a second challenge with ovalbumin aerosol, as above
reported.
Groups 7 and 8: 12 guinea pigs were treated as described
for group 2. The animals of group 7 were exposed for 10
min to an aerosol of histaminase immobilized on CNBr-
Sepharose at the dose of 4 Ag/ml (flow rate 0.5 ml/min). The
animals of group 8 were exposed to the second challenge
with ovalbumin aerosol in the presence of histaminase
immobilized on CNBr-Sepharose at the dose of 4 Ag/ml.
Two groups of six sensitized guinea pigs and two groups
of six naive animals were treated i.p. with 20 Ag of free or
immobilized histaminase to evaluate the concentrations of
the enzyme in plasma and in several organs, such as lung,
liver, kidney, and heart. Blood samples were obtained at
time 0, and 3, 6, 9, and 18 h after animal treatment. One-half
milliliter of blood, obtained with an intracardiac puncture,
was immediately centrifuged to obtain plasma which was
frozen at 20 8C until use. At 24 h after enzyme
administration, the animals were anesthetized, exsangui-
nated, and about 300 mg of tissue samples of heart, lungs,
kidney, and liver were obtained, washed in saline, and
immediately frozen at 20 8C until use.
2.4. Evaluation of respiratory functional parameters
The guinea pigs of all studied groups were placed, one by
one, in a whole body respiratory chamber, as described byBallati et al. (1992), Evangelista et al. (1995), and Bani et al.
(1997). The changes in inner pressure in the respiratory
chamber induced by breathing were monitored with a high
sensitivity pressure transducer (Battaglia-Rangoni, Bologna,
Italy; pressure and linearity ranges from 10 to +10 mm
Hg) connected to a PC2400A channel of a polygraph
(Battaglia-Rangoni). Upon stabilization of the breathing
pattern (usually occurring within 30–60 s), the guinea pigs
from groups 1–8 were challenged with an aerosol of
ovalbumin (5 mg/ml in saline) for 10 s. With a Millipore
pump, at 5 bar insufflation pressure, very small aerosol
particles can be obtained, as assessed in previous tests (Bani
et al., 1997). The nonsensitized guinea pigs of group 1 were
included in the aerosol challenge to reveal possible
alterations in the breathing pattern due to a specific
stimulation of the airways by the aerosol droplets. The
changes in the respiratory activity of the animals subjected
to the different treatments were recorded for 5 min after the
aerosol administrations.
The following parameters were evaluated according to
Evangelista et al. (1995): (a) latency time, in seconds, for
the appearance of the respiratory abnormalities, assessed as
the time between the onset of aerosolization and the first
cough stroke, a cough stroke being assumed as a
respiratory movement whose amplitude exceeded by at
least 10% that of normal breath preceding the cough
stroke; (b) cough severity score, assessed as the product of
cough frequency and mean cough amplitude, assuming as
cough frequency the number of cough strokes per minute
and as cough amplitude the excess pressure, in millimeters
of Hg, over the normal breath preceding the cough stroke.
In addition, (c) occurrence of dyspnea, recognized in
breath recordings as a series of irregular breaths of
abnormally elevated or reduced amplitude compared with
the basal breath, was reported.
To evaluate airway hyperresponsiveness, animals of
groups 1, 2, and 4 were exposed to increasing doses of
methacholine (MeCh, Sigma, Milan, Italy), ranging from
2.5 to 50 mg/ml in saline. Each dose was administered by
nebulization for 10 s in the same respiratory chamber as
above with 30-s intervals as previously reported (Park et al.,
2001). Three hours before the MeCh provocation test, the
animals from groups 1 to 7 received a second treatment with
vehicle, or histaminase, as previously reported. Changes in
the respiratory activity of the animals subjected to the MeCh
provocation test were recorded in the same manner as for
ovalbumin challenge.
2.5. Biochemical and morphological analysis
Thirty minutes after the extraction from the respiratory
chamber, the guinea pigs were euthanized by lethal i.p.
injections of sodium thiopental (Pentothal, Abbott, Latina,
Italy). At death, the thorax was opened to allow the lungs to
be examined, and tissue specimens from the middle lobe of
the right lung were excised from each animal and processed
Table 1
Histaminase content in various organs and plasma (n=6; pmol/mg protein,
meanFS.E.M.) of sensitized animal treated with free or immobilized
enzyme
Tissues (18 h) Free Immobilized
Lung 60F10 107F10
Liver 43F58 112F14
Heart 68F13 139F10
Kidney 46F4 83F20
Plasma
0 h 0 0
3 h 642F20 272F5
6 h 779F12 90F8
9 h 557F30 39F18
18 h 58F5 0
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light microscopy.
For light microscopic study of lung mast cells, the tissue
samples, two from each animal, were fixed by immersion
in Mota fluid, dehydrated in graded ethanol, and embedded
in paraffin wax. Sections 5 Am thick were cut and stained
with hematoxylin and eosin for conventional histology and
morphometry of lung alveoli and small-sized bronchi or
with Astra blue, which selectively binds heparin to reveal
metachromasia of mast cell granules. A first series of
determinations was carried out on hematoxylin- and eosin-
stained sections to evaluate the surface area of alveolar
aerial spaces. Four randomly chosen microscopical fields
per animal (two fields per section) were analyzed. At the
chosen magnification, each field corresponds to a tissue
area of 570 Am2 that includes an average of 300 alveolar
profiles. The same tissue sections were used to evaluate the
surface area of bronchial lumina. Light transmittance
across mast cells, which is inversely related to their
granule content, was evaluated by a computer-assisted
method, as described previously (Masini et al., 1994). The
transmission of at least 20 different mast cells chosen at
random from animals of the different groups was analyzed,
and the mean transmission value (FS.E.M.) was then
calculated.
Evaluation of luminal area of alveoli and bronchioli in
the lung was performed by computer-aided morphometry,
according to a method used previously to evaluate the
surface area of lung blood vessel (Bani et al., 1997), with
minor modifications. Determinations were carried out on
hematoxylin- and eosin-stained histological sections, 6 Am
thick, coming from lung tissue from the different groups.
For each experimental group, the mean surface area
(FS.E.M.) was then calculated.
2.6. Immunohistochemisty for eosinophil identification
This was carried out on histological sections, 5 Am thick,
of Mota-fixed, paraffin-embedded lung tissue fragments.
Sections were rehydrated, treated with 0.1% trypsin for 10
min to retrieve antigen, then with 0.3% (v/v) H2O2 in 60%
(v/v) methanol to quench endogenous peroxidase, and,
finally, incubated overnight with mouse monoclonal antihu-
man eosinophil major basic protein (MBP) antibodies (clone
BMK13, Chemicon, Temecula, CA; 1:50 in PBS). Immune
reaction was revealed by indirect immunoperoxidase
method (Vectastain Elite kit, Vector, Burlingame, CA),
using 3,3V-diaminobenzidine as chromogen. As negative
controls, sections incubated with only the primary or the
secondary antisera were used. Observations were carried out
with a Reichert–Jung Microstar IV light microscope (Cam-
bridge Instruments, Buffalo, NY). In each guinea pig, the
number of MBP-positive eosinophils was counted in 10
randomly chosen microscopical fields at a 200 final
magnification (test area: 72,346 Am2). Values obtained from
two different observers were averaged.2.7. Determination of lung tissue myeloperoxidase activity
Myeloperoxidase activity, a hemoprotein located in
azurophil granules of neutrophil and eosinophil granulo-
cytes, has been used as a marker for granulocyte accumu-
lation in tissue (Bradley et al., 1982; Mullane et al., 1985).
Myeloperoxidase activity was evaluated photometrically
according to Bradley et al. (1982). Briefly, frozen lung
tissue samples weighing approximately 100 mg were
minced and homogenized in 1.5 ml of 50 mM potassium
phosphate buffer, pH 6. One milliliter of the homogenate
was centrifuged at 10,000g for 10 min, and the pellet was
suspended in 1 ml of 150 mM potassium phosphate buffer,
pH 6, containing 0.5% hexa-decyl-trimethyl-ammonium
bromide to negate the pseudoperoxidase activity of hemo-
globin and to solubilize membrane-bound myeloperoxidase.
The suspension was treated with three cycles of freezing–
thawing, sonicated on ice for 10 s, and centrifuged at
12,000g for 30 min. Myeloperoxidase was determined in
the supernatants as previously reported (Griswold et al.,
1989). The myeloperoxidase unit was defined as the
quantity of enzyme catalyzing 1 Amol of substrate with 1
Amol of hydrogen peroxide per minute at 25 8C and was
expressed in milliunits per milligram protein. Protein
concentration was determined with the Bradford method
(Bradford, 1976).
2.8. Determination of lung tissue malonyldialdehyde
production
Malonyldialdehyde is an end product of peroxidation of
cell membrane lipids and is considered a reliable marker of
oxygen-derived free radical damage (Masini et al., 2002a).
It was determined by measuring of the chromogen
obtained from the reaction of malonyldialdehyde with 2-
thiobarbituric acid according to Aruoma et al. (1989).
Approximately 100 mg of lung tissue was homogenized
with 1 ml of 50 mM Tris–HCl buffer containing 180 mM
KCl and 10 mM EDTA, pH 7.4, using a tissue
homogenizer. A volume of 0.5 ml of 2-thiobarbituric acid
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water) were added to 0.5 ml of samples. An aliquot (100
Al) of the homogenate was added to a reaction mixture
containing 200 Al of 8.1% (w/v) sodium dodecyl sulphate
(SDS), 1500 Al of 20% (w/v) acetic acid (pH 3.5), 1500 Al
of 0.8% (w/v) thiobarbituric acid, and 700 Al of distilled
water. The mixture was placed in test tubes, sealed with
screw caps, and heated in boiling water for 10 min. After
cooling, the chromogen was extracted in 3 ml of 1-butanol,Fig. 1. Effects of CNBr-Sepharose 6MB immobilized histaminase (20 Ag given i.p
Ag/ml p.a. during ovalbumin challenge) and of chlorpheniramine (30 Ag/ml p.a. 3
dyspnea (C) induced by ovalbumin challenge in sensitized guinea pigs. Data are ex
boxes represent interquartile ranges, and whiskers represent extreme values. *Pb0.
ovalbumin.and the organic phase was separated by centrifugation at
3000g for 10 min. The absorbance of the organic phase
was read spectrophotometrically at 600 nm wavelength.
Protein concentration was determined with the Bradford
method (Bradford, 1976).
The values were expressed as nanomoles of thiobarbitu-
ric acid-reactive substances (malonyldialdehyde equiva-
lence) per milligram protein, using a standard curve of
1,1,3,3-tetramethoxypropane.. 3 or 24 h before ovalbumin, or 4 Ag/ml p.a. 30 min before ovalbumin or 4
0 min before ovalbumin) on cough latency (A), severity of cough (B), and
pressed as box plot of 12 experiments; black lines represent median values,
01 vs. sensitized animals and chlorpheniramine 30 Ag/ml p.a. 30 min before
E. Masini et al. / European Journal of Pharmacology 502 (2004) 253–2642582.9. Materials
Ovalbumin was obtained from Fluka (Buchs, Switzer-
land); 3,3Vdiaminobenzidine tetrahydrochloride, putrescine,
homovanillic acid, horseradish peroxidase hexadecyl-trime-
thylammonium bromide, semicarbazide were obtained from
Sigma (St. Louis, MO, USA). CNBr-Sepharose 6MB was
obtained from Pharmacia (Central Milton, Keines, UK). All
other reagents were used of Suprapur quality for spectro-
scopy were from Merck (Milan, Italy).
2.10. Statistical analysis
The reported data are expressed as the meanFS.E.M. of
at least 6 independent experiments. Statistical analysis was
performed by Kruskal–Wallis H multiple comparison test
followed by the Mann–Whitney U-test for independent
samples. Calculations were carried out using SPSS 11.0.0
(SPSS Inc), with Pb0.05 being considered as significant.3. Results
3.1. Levels of free and immobilized histaminase in plasma
and in organs
The amount of free and immobilized histaminase in lung
and liver of sensitized guinea pigs after an injection of 20
Ag, i.p., corresponding to a specific activity of 40 IU mg1
protein of both enzymes is reported in Table 1. In the plasma
and lung of naRve animals, no detectable histaminase
activity was found. The histaminase activity in plasma,
lung, and liver in the sensitized animals treated with free and
immobilized enzyme was high at 3–6 h and decreased later.
In the group of the sensitized guinea pigs, the values of
enzymatic activity in lung, liver, and heart were twice asFig. 2. Effect of CNBr-Sepharose 6MB immobilized histaminase (20 Ag given
concentrations of MeCh in sensitized guinea pigs. Comparison with untreated se
experiments. *Pb0.01 vs. sensitized animals.high in the animals treated with immobilized enzyme as in
those treated with the free form (Table 1).
3.2. Respiratory functional parameters
The median values of the respiratory parameters are
reported in Fig. 1. There were no substantial abnormalities
in the nonsensitized guinea pigs (naRve animals, group 1)
after inhalation of an aerosol of ovalbumin (5 mg/ml),
except for some sporadic cough strokes arising about 2–3
min after the onset of the aerosol treatment.
Challenge of sensitized guinea pigs (group 2) with
ovalbumin aerosol resulted in evident abnormalities in the
respiratory pattern, consisting in a significant reduction of
cough latency time (Fig. 1A), a significant increase in the
severity of cough (Fig. 1B), and in the occurrence of
episodes of dyspnea in the breath recordings (Fig. 1C).
Conversely, the treatment of the animals with free or CNBr-
Sepharose 6MB immobilized histaminase at the dose of 20
Ag, i.p., 3 or 24 h before ovalbumin aerosol or per aerosol at
the dose of 4 Ag 30 min before or during ovalbumin
challenge with a rate of 1 ml/min for 5 min (corresponding
to a total dose of 0.8 IU), resulted in a significant reduction
in respiratory abnormalities compared with those presented
in the animals of group 2 receiving the administration of
buffered saline. In particular, the cough latency time was
significantly increased (Fig. 1A), and the severity of cough
was significantly reduced (Fig. 1B) upon administration of
free or immobilized histaminase i.p. or per aerosol. The
clearcut signs of dyspnea in the breath recordings of the
animals treated with histaminase were significantly delayed
and less severe than in the group of untreated ones (Fig.
1C). The maximal protective effect in delaying the
appearance of respiratory abnormalities or in decreasing
the cough severity was observed when the enzyme was
given per aerosol together with ovalbumin challenge (Fig.i.p. 3 h before ovalbumin) on severity of cough induced by increasing
nsitized and naRve animals. Data are expressed as meanFS.E.M. of eight
Fig. 3. Representative light micrographs of lung tissue from guinea pigs of the different experimental groups. Compared to the nonsensitized controls (A), in
the sensitized animals undergoing ovalbumin aerosol (B), a clearcut dilation of alveolar aerial spaces and constriction of small-sized muscular bronchi can be
observed. These alterations are prevented by histaminase pretreatment before ovalbumin challenge (C). Hematoxylin and eosin staining; bars=100 Am.
E. Masini et al. / European Journal of Pharmacology 502 (2004) 253–264 2591). Semicarbazide inactivated histaminase was completely
ineffective on all the functional parameters examined (data
not reported).
The results of the respiratory parameters after the
metacholine provocation test are reported in Fig. 2.
Histaminase determined a significant ( pb0.01) reduction
in airway hyperresponsiveness evaluated as cough severity
score (Fig. 2).
3.3. Morphology and morphometry of lung, bronchi, and
mast cells after ovalbumin challenge
3.3.1. Morphology
Macroscopic examination of the lungs showed prominent
changes in the sensitized guinea pigs challenged with the
antigen (group 2) compared with the nonsensitized guinea
pigs (group 1) or the sensitized animals not exposed to
aerosol. These changes mainly consisted in marked swelling
of the pulmonary lobes due to air accumulation. The section
of trachea or of main bronchi did not cause lung deflation,
thus indicating that peripheral airway obstruction had
occurred. Lung inflation was not observed in all sensitizedFig. 4. Mast cell metachromatic granule content, measured as increased light transm
animals, sensitized animals after ovalbumin challenge, and from sensitized anima
ovalbumin challenge. Data are expressed as meanFS.E.M. of 12 experiments. *Pguinea pig groups treated with histaminase (groups 3–8).
Light microscopy of lung tissue showed that the intra-
pulmonary bronchi and respiratory air space of control
guinea pigs in group 1 had a normal appearance. In
particular, intrapulmonary bronchi showed open lumina
with bronchial mucosa forming short folds, and the
respiratory air spaces were small (Fig. 3A). On the contrary,
lung tissue from the sensitized guinea pigs challenged with
the antigen (group 2) showed a reduction of the intra-
pulmonary bronchial lumen. In large areas of the lung
parenchyma, the respiratory air spaces were markedly
dilated by accumulation of trapped air (Fig. 3B). In
sensitized guinea pigs treated with histaminase, the histol-
ogy and abnormalities following ovalbumin-induced reac-
tion were nearly abrogated. In fact, the intrapulmonary
bronchi usually showed no appreciable signs of constriction,
and the respiratory air spaces were not dilated (Fig. 3C).
Attenuated signs of bronchoconstriction and dilation of
respiratory air spaces were observed only in small areas of
lung parenchyma. Histaminase alone, without sensitizing
and/or treating with ovalbumin, was completely ineffective
(data not shown).ittance. Optical density of mast cells from lungs of naRve animals, sensitized
ls pretreated with free or immobilized histaminase (20 Ag, i.p.) 3 h before
b0.01 vs. sensitized animals.
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Mast cell densitometry revealed a significant increase in
light transmittance, indicating a decrease in the metachro-
matic granule content of the cells, in mast cells from
sensitized guinea pigs challenged with ovalbumin (group 2)
compared with those in the control, unsensitized animals of
group 1. In mast cells of the sensitized guinea pigs, treated
i.p. 3 h before ovalbumin challenge both with 20 Ag of free
or immobilized histaminase, the light transmittance was not
modified in comparison to the values obtained in the
sensitized animals challenged with ovalbumin and treated
with vehicle (Fig. 4). These results clearly indicate that
histaminase did not produce any chromoglycate-like effect
on antigen-induced degranulation of lung mast cells.
The morphometric analysis of the luminal area of alveoli
in guinea pigs treated with histaminase was significantly
reduced (Pb0.001) when compared to the buffered saline-Fig. 5. Morphometric analysis of luminal area of alveoli (A) and luminal area of br
sensitized animals, sensitized animals after ovalbumin challenge, and from sensitiz
before ovalbumin challenge. Data are expressed as meanFS.E.M. of 12 experimtreated group (Fig. 5A); meanwhile, the luminal area of lung
peripheral bronchi was also significantly (Pb0.001)
increased in guinea pigs treated with histaminase (Fig.
5B). These results clearly indicate that the treatment of the
guinea pigs with histaminase results in a significant
bronchodilation, as shown by increasing the luminal area
of bronchi and decreasing air accumulation in the alveoli.
3.4. Leukocyte infiltration and lipid peroxidation in lung
tissue
Detection of MBP-positive eosinophils showed almost
no cells in the unsensitized guinea pigs, whereas a few
scattered positive cells could be observed in the sensitized,
not challenged animals. Immunostained cells increased
markedly in the sensitized, ovalbumin-challenged guinea
pigs. They were mostly located in the inflammatoryonchioli (B). Quantification of the effects on lung architecture obtained from
ed animals pretreated with free or immobilized histaminase (20 Ag, i.p.) 3 h
ents. *Pb0.01 vs. ovalbumin.
Fig. 6. Effects of free or immobilized histaminase (20 Ag, i.p., 3 h before ovalbumin) on the amount of MBP-immunoreactive lung eosinophils in lung tissue
obtained from naRve animals, sensitized animals, sensitized animals after ovalbumin challenge, and from sensitized animals pretreated with free or immobilized
histaminase (20 Ag, i.p., 3 h before ovalbumin challenge). Data are expressed as meanFS.E.M. of 12 experiments. *Pb0.01 vs. ovalbumin.
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septa. In the sensitized, ovalbumin-challenged guinea pigs
pretreated with histaminase, immunostained cells were
markedly reduced, thus attaining values similar to the
unsensitized controls (Fig. 6).
Furthermore, myeloperoxidase activity, a marker of
leukocyte infiltration into inflamed tissues, underwent a
marked, significant increase in the sensitized guinea pigs
challenged with ovalbumin (group 2) compared with naRve
animals (group 1) as (Fig. 7). Both free and immobilized
histaminase significantly decreased (Pb0.001) the activity
of myeloperoxidase in lung tissue.
It is well known that malonyldialdehyde production,
measured as equivalent of thiobarbituric acid, is a suitable
index of membrane lipid peroxidation and cell damage (Rao
et al., 1983). In our experiments, antigen challenge inFig. 7. Effects of free or immobilized histaminase (20 Ag, i.p., 3 h before oval
sensitized animals, sensitized animals after ovalbumin challenge, and from sensitiz
before ovalbumin challenge. Data are expressed as meanFS.E.M. of 12 experimsensitized guinea pigs of group 2 produced a significant
increase in malonyldialdehyde production in comparison to
naRve animals of group 1. In lungs from animals treated with
both free or immobilized histaminases, a significant
decrease in malonyldialdehyde production took place at a
level comparable to that of unsensitized animals of group 1
(Fig. 8). No differences in potency were noted between free
or immobilized histaminases.4. Discussion
The results of this study indicate that two forms (free and
immobilized) of pea seedling histaminase counteract the
pulmonary asthmalike response to inhaled antigen in
sensitized guinea pigs, as well as the increased responsive-bumin) on myeloperoxidase (MPO) activity in lung tissue obtained from
ed animals pretreated with free or immobilized histaminase (20 Ag, i.p.) 3 h
ents. *Pb0.01 vs. ovalbumin.
Fig. 8. Effects of free or immobilized histaminase (20 Ag, i.p., 3 h before ovalbumin) on malonyldialdehyde (MDA) production in lung tissue obtained from
sensitized animals, sensitized animals after ovalbumin challenge, and from sensitized animals pretreated with free or immobilized histaminase (20 Ag, i.p.) 3 h
before ovalbumin challenge. Data are expressed as meanFS.E.M. of 12 experiments. *Pb0.01 vs. ovalbumin.
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provocation test. An evaluation of the respiratory activity of
sensitized guinea pigs shows that treatment with histaminase
nearly eliminates the breathing abnormalities typical of
airway hyperresponsiveness to the inhaled antigen.
This effect of pea seedling histaminase is accompanied
by a marked reduction in the histological signs of lung
injury in response to antigen challenge, such as bronchial
constriction, dilation of respiratory air spaces, leukocyte
infiltration, and lipid peroxidation. The mechanisms by
which histaminase exerts its beneficial action probably rely
on the inactivation of histamine released by resident mast
cells afforded by the enzyme.
It was surprising that higher amounts of histaminase
were found in lung, liver, and heart when the immobilized
form was administered. The distribution of this conjugate
via the circulation can be explained by the fact that the
support used, CNBr-activated agarose (CNBr-Sepharose
6MB), was not cross-linked and thus tends to melt at body
temperature. The distribution of the conjugate in various
organs may be facilitated by the galactose units present in
the structure of agarose supports: the uncross-linked
agarose exhibiting galactose units can be retained by
carbohydrate-binding proteins in organs and tissues, and
thus the plasma concentration appears lower. The con-
jugate of histaminase with the activated Sepharose presents
several advantages. The most important is that this support
is an uncross-linked agarose, which when administered
will first become soft and then can even melt, allowing the
uptake by cells or a deeper interaction with membranes.
Furthermore, the enzyme conjugate with agarose was
shown to be more stable at proteolysis or denaturing
factors (Federico et al., 2000). The behavior of histami-
nase–agarose conjugates can prefigure the use of other
polymeric conjugates of this therapeutic enzyme.Histamine and superoxide anion are released from lung
mast cells after antigen challenge. These mediators are
responsible for bronchoconstriction, vessel edema and
neutrophil, and eosinophil recruitment from the circulation
to the lung, as indicated by the presence of degranulated
mast cells (Bani et al., 1997; O’Sullivan et al., 1998;
Brightling et al., 2002) and by the increase in myeloper-
oxidase activity, a marker of granulocyte accumulation in
tissue (Bradley et al., 1982) after antigen challenge.
Pea seedling histaminase has been shown to strongly
decrease eosinophil and neutrophil leukocyte recruitment,
both through the oxidation of histamine and the scavenging
of free radicals, two elements which are known to promote
neutrophil and eosinophil chemotaxis (O’Sullivan et al.,
1998; Brightling et al., 2002). This effect is evidenced by the
decreased myeloperoxidase activity and the low number of
MBP-immunoreactive eosinophils in the inflammatory
infiltrate surrounding the bronchi in histaminase-treated
guinea pigs. In turn, neither free nor immobilized histami-
nase modified the increase in light transmission through lung
mast cells in response to antigen, meaning that the two forms
of enzyme do not produce any cytoprotective membrane
stabilizing chromoglycate-like effect on the antigen-evoked
degranulation of mast cells.
It was previously shown that copper proteins, such as
ceruloplasmin (Chahine et al., 1991; Mateescu et al., 1995;
Atanasiu et al., 1998) and serum aminoxidase (Mateescu et
al., 1997; Mondovi et al., 1997), exhibit a powerful
antioxidant capacity, stronger than that of known antiox-
idant agents, such as deferoxamine (Atanasiu et al., 1995)
and superoxide dismutase (Dumoulin et al., 1996), and that
this antioxidant activity does not seem to be related to the
enzymatic activities of these copper oxidases. It is there-
fore likely that copper histaminase exerts similar antiox-
idant capacities. In fact, histaminase was recently shown
E. Masini et al. / European Journal of Pharmacology 502 (2004) 253–264 263(Masini et al., 2003) to protect the rat against ischemia-
and reperfusion-induced oxidative damage, with a cardio-
protective pattern similar to that of ceruloplasmin (Atana-
siu et al., 1995) and of serum amineoxidase (Mondovi et al.,
1997).
The enzyme does not seem to act through the blockade of
H1 receptors. Classical antihistamines are in fact scarcely
effective in preventing granulocyte recruitment (Townley,
1992; Eda et al., 1994), and, as shown in Fig. 1, the classic
H1 blocker chlorpheniramine (30 Ag/ml p.a. 30 min before
antigen challenge) is significantly less effective than
histaminase in the prevention of asthmalike reactions.
Histaminase has also been shown to strongly decrease
the production of malonyldialdehyde, a lipid peroxidation
metabolite, in lungs from guinea pigs exposed to ovalbumin
aerosol. This finding clearly indicates that pea seedling
histaminase is able to reduce peroxidation of cell membrane
lipids induced by oxygen-derived free radicals generated
during antigen-induced bronchospasm (Calhoun et al.,
1992), thus offering protection to cells that could be
damaged by them.
In this sense, it has recently been shown that bovine
serum amine oxidases exert an in vitro antioxidant effect on
electrolysis-induced oxidative species and an ex vivo
cardioprotective action on oxidative injury in isolated rat
heart (Mateescu et al., 1997), and these effects are similar to
those of cardioprotective and antioxidant drugs, such as
mannitol or desferoxamine (Mateescu et al., 1997).
It is well known that, besides histamine, reactive oxygen
species play a key role in allergic asthma and other
inflammatory lung diseases (Eiserich et al., 1998; de Boer
et al., 2001). These species are cytotoxic because they
induce cellular oxidative stress, which can cause cellular
dysfunction, damage, and, eventually, cell death. Several
reports have shown that inflammatory cells produce large
amounts of superoxide anions in asthma attacks and that an
inverse correlation exists between neutrophil infiltration,
superoxide production, and airway obstruction (Jarjour and
Calhoun, 1994). In our previous report (Masini et al.,
2002b), we demonstrate protection by pea seedling hista-
minase against cardiac anaphylactic shock, owing to
decreased anaphylactic release of histamine in the treated
animals. Altogether, our results show that histaminase can
reduce the infiltration of neutrophils into lung tissue, lipid
peroxidation, and acute bronchospastic reaction and
strongly suggest that this plant histaminase may be useful
in the treatment of allergic diseases.Acknowledgements
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